¿Ã·¹Æ÷Æ® : ´ëÇз¹Æ÷Æ®, Á·º¸, ½ÇÇè°úÁ¦, ½Ç½ÀÀÏÁö, ±â¾÷ºÐ¼®, »ç¾÷°èȹ¼­, Çо÷°èȹ¼­, ÀÚ±â¼Ò°³¼­, ¸éÁ¢, ¹æ¼ÛÅë½Å´ëÇÐ, ½ÃÇè ÀÚ·á½Ç
¿Ã·¹Æ÷Æ® : ´ëÇз¹Æ÷Æ®, Á·º¸, ½ÇÇè°úÁ¦, ½Ç½ÀÀÏÁö, ±â¾÷ºÐ¼®, »ç¾÷°èȹ¼­, Çо÷°èȹ¼­, ÀÚ±â¼Ò°³¼­, ¸éÁ¢, ¹æ¼ÛÅë½Å´ëÇÐ, ½ÃÇè ÀÚ·á½Ç
·Î±×ÀΠ ȸ¿ø°¡ÀÔ

ÆÄÆ®³Ê½º

ÀÚ·áµî·Ï
 

Àå¹Ù±¸´Ï

´Ù½Ã¹Þ±â

ÄÚÀÎÃæÀü

¢¸
  • [°£È£] ¸¸¼º½ÅºÎÀü°ü·Ã Àú³ÎÇØ¼®   (1 ÆäÀÌÁö)
    1

  • [°£È£] ¸¸¼º½ÅºÎÀü°ü·Ã Àú³ÎÇØ¼®   (2 ÆäÀÌÁö)
    2

  • [°£È£] ¸¸¼º½ÅºÎÀü°ü·Ã Àú³ÎÇØ¼®   (3 ÆäÀÌÁö)
    3

  • [°£È£] ¸¸¼º½ÅºÎÀü°ü·Ã Àú³ÎÇØ¼®   (4 ÆäÀÌÁö)
    4

  • [°£È£] ¸¸¼º½ÅºÎÀü°ü·Ã Àú³ÎÇØ¼®   (5 ÆäÀÌÁö)
    5


  • º» ¹®¼­ÀÇ
    ¹Ì¸®º¸±â´Â
    5 Pg ±îÁö¸¸
    °¡´ÉÇÕ´Ï´Ù.
¢º
Ŭ¸¯ : Å©°Ôº¸±â
  • [°£È£] ¸¸¼º½ÅºÎÀü°ü·Ã Àú³ÎÇØ¼®   (1 ÆäÀÌÁö)
    1

  • [°£È£] ¸¸¼º½ÅºÎÀü°ü·Ã Àú³ÎÇØ¼®   (2 ÆäÀÌÁö)
    2

  • [°£È£] ¸¸¼º½ÅºÎÀü°ü·Ã Àú³ÎÇØ¼®   (3 ÆäÀÌÁö)
    3

  • [°£È£] ¸¸¼º½ÅºÎÀü°ü·Ã Àú³ÎÇØ¼®   (4 ÆäÀÌÁö)
    4

  • [°£È£] ¸¸¼º½ÅºÎÀü°ü·Ã Àú³ÎÇØ¼®   (5 ÆäÀÌÁö)
    5



  • º» ¹®¼­ÀÇ
    (Å« À̹ÌÁö)
    ¹Ì¸®º¸±â´Â
    5 Page ±îÁö¸¸
    °¡´ÉÇÕ´Ï´Ù.
  ´õºíŬ¸¯ : ´Ý±â
X ´Ý±â
Á¿ìÀ̵¿ : µå·¡±×

[°£È£] ¸¸¼º½ÅºÎÀü°ü·Ã Àú³ÎÇØ¼®

ÀÎ ¼â
¹Ù·Î°¡±â
Áñ°Üã±â Űº¸µå¸¦ ´­·¯ÁÖ¼¼¿ä
( Ctrl + D )
¸µÅ©º¹»ç ¸µÅ©ÁÖ¼Ò°¡ º¹»ç µÇ¾ú½À´Ï´Ù.
¿øÇÏ´Â °÷¿¡ ºÙÇô³Ö±â Çϼ¼¿ä
( Ctrl + V )
¿ÜºÎ°øÀ¯
ÆÄÀÏ  [°£È£] ¸¸¼º½ÅºÎÀü°ü·Ã Àú³ÎÇØ¼®.hwp   [Size : 19 Kbyte ]
ºÐ·®   5 Page
°¡°Ý  1,000 ¿ø


īƮ
´Ù¿î¹Þ±â
īī¿À ID·Î
´Ù¿î ¹Þ±â
±¸±Û ID·Î
´Ù¿î ¹Þ±â
ÆäÀ̽ººÏ ID·Î
´Ù¿î ¹Þ±â
µÚ·Î

¸ñÂ÷/Â÷·Ê
`¿ø¹®`
Á¦¸ñ: Antithrombotic Prophylaxis and Therapy in Renal
Failure...Hartmann B, Czock D, Keller F: Drug therapy in patients with
chronic renal failure. Dtsch Arztebl Int 2xxx; 107(37): 647-56.
-ÀúÀÚ: Kienitz, Carsten; Rosin, Ludger; Paar, W. Dieter
-¼Ò¼Ó±â°ü: Sanofi-Aventis Deutschland GmbH Potsdamer Str. 8 10785 Berlin,
Germany
-¼ö·Ï ÃâÆÇ¹°: Deutsches Aerzteblatt International (DTSCH AERZTEBL INT),
2/18/2xxx; 108(7): 112-113. (2p)
-ÃâÆÇ¹° À¯Çü: Journal Article ...
º»¹®/³»¿ë

`¿ø¹®`

Á¦¸ñ: Antithrombotic Prophylaxis and Therapy in Renal
Failure...Hartmann B, Czock D, Keller F: Drug therapy in patients with
chronic renal failure. Dtsch Arztebl Int 2xxx; 107(37): 647-56.

-ÀúÀÚ: Kienitz, Carsten; Rosin, Ludger; Paar, W. Dieter
-¼Ò¼Ó±â°ü: Sanofi-Aventis Deutschland GmbH Potsdamer Str. 8 10785 Berlin,
Germany
-¼ö·Ï ÃâÆÇ¹°: Deutsches Aerzteblatt International (DTSCH AERZTEBL INT),
2/18/2xxx; 108(7): 112-113. (2p)
-ÃâÆÇ¹° À¯Çü: Journal Article - commentary, letter
-¾ð¾î: English
-ÁÖ¿ä ÁÖÁ¦¸í: Heparin, Low-Molecular-Weight Therapeutic Use
Kidney Failure, Chronic
-ºÎÂ÷ ÁÖÁ¦¸í: Heparin, Low-Molecular-Weight Administration and Dosage;
Thromboembolism Risk Factors
-Àú³Î ÇÏÀ§ÁýÇÕ: Biomedical; Blind Peer Reviewed; Continental Europe;
Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed

The authors postulate a `deep compartment` for enoxaparin. This is
su¡¦(»ý·«)



📝 Regist Info
I D : dldm****
Date : 2018-06-15
FileNo : 18084443

Cart